Skip to main content
All tenders

Drug Discount Agreements Omalizumab 2025-29

Status
Active
Submission Deadline
424 days remaining
Contracting authority
Techniker Krankenkasse144 more open tenders view
Location
Hamburg, Germany
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
ted-347743-2026
Source
View original source

We are seeking partners for drug discount agreements for the active ingredient Omalizumab through an open-house procedure for the years 2025 to 2029.

Free

Never miss a tender again

We send you 3 current matches that fit your company.

We call you once briefly to sharpen your search profile.

No account neededReply in 1-2 business days

By submitting, you agree that Patterno sends you matching tenders by email. Free, unsubscribe anytime. Privacy policy

Tender documents

  • Portal — LOT-0001NON-RESTRICTED-DOCUMENT
  • TED HTML — 347743-2026HTML
  • TED PDF — 347743-2026PDF
  • TED XML — 347743-2026XML
Free

Unlock documents for free

Enter your email address. If you confirm, we will also send you 3 similar tenders.

We call you once briefly to sharpen your search profile.

No account neededReply in 1-2 business days

By submitting, you agree that Patterno sends you matching tenders by email. Free, unsubscribe anytime. Privacy policy

Additional details

EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
Not allowed
Legal Basis
32014L0024

Similar tenders

Explore CPV 33
Live webinar

See Patterno work on a real tender

45 minutes live, questions answered in the chat. Upcoming dates on the signup page.

  • Matches from 4,500+ portals in one workspace
  • Qualify any tender against your criteria in minutes
  • Prepare bid documents from your company context
Register for the live webinar

Prefer a private session?